| abstract |
Use of a nicotine receptor agonist or a pharmaceutically acceptable salt thereof for the production of a pharmaceutical preparation for the treatment of obsessive compulsive disorder is disclosed, as well as a method for treatment of a patient suffering from obsessive compulsive disorder, comprising the administration of a nicotine receptor agonist or a pharmaceutically acceptable salt thereof, in an amount effective in alleviating, reducing or abolishing one or several of the symptoms of obsessive compulsive disorder. |